Follow the CSJ LinkedIn page. Search Clinical Services Journal
Thousands of doctors face bullying and discrimination, but fear speaking out
Thousands of doctors are experiencing bullying and discrimination at work, but many do not believe it is safe or worthwhile to report, according to a survey published by the General Medical Council (GMC).
Almost one in four (23%) locally employed (LE)
doctors and nearly one in three (31%) of specialty, associate specialist and specialist (SAS) doctors said they had experienced or witnessed bullying or harassment in their role. Consultants were most often identified as the source of bullying and undermining behaviour. Among those who chose not to report incidents
where they worked, 67% of both LE and SAS doctors said they believed reporting would not make a difference. More than half – 60% of LE doctors and 54% of SAS doctors – also feared adverse consequences, such as on their careers or relationships with colleagues. LE and SAS doctors are practitioners who
provide patient care, but who are not in formal training posts that lead to becoming consultants or GPs. SAS doctors are usually experienced clinicians who view the role as a long-term career path, whereas LE doctors can have a variety of contract types and job titles and are often early in their careers. They are two of the fastest growing cohorts of
doctors in the UK, accounting for nearly a fifth of all doctors. Much of the growth in recent years is driven by doctors who qualified overseas. The GMC’s survey, the first major survey of LE
and SAS doctors for seven years, asked them about their roles, motivations, workplace experiences and their access to training and development. More than 10,500 doctors – 5,221 LE and 5,359 SAS – responded.
of others, compared with 18% of UK-qualified SAS doctors. Doctors who qualified outside the UK were also less confident about challenging and reporting discrimination. Less than half, 45%, of internationally qualified LE doctors said they felt confident challenging discrimination, compared with 58% of those who qualified in the UK. Charlie Massey, Chief Executive of the GMC said: “It is deeply troubling that doctors tell us bullying and discrimination are still common and that many fear speaking up will make no difference, or might even lead to repercussions. “SAS and locally employed doctors make an
The survey found that internationally qualified
doctors were more likely to report negative workplace experiences than their UK-qualified colleagues.
Among LE doctors, nearly half (45%) of
internationally qualified doctors reported experiencing micro-aggressions, such as negative comments or oppressive body language, compared to 37% of UK-qualified doctors. Fourteen per cent said they experienced these behaviours daily or weekly. Internationally qualified LE doctors were
also more likely to report being excluded from workplace interactions, with 32% reporting this compared with 19% of UK-qualified colleagues. Among SAS doctors, 31% of internationally qualified doctors said they were not given the same training opportunities as their peers, compared with 18% of UK-qualified doctors. A quarter (25%) said they had been intentionally humiliated in front
invaluable contribution to the NHS, bringing a wealth of skills and experience to patient care. Yet, too many continue to report poorer workplace experiences and feel less confident challenging discrimination. “The findings suggest that having reporting
procedures in place is not enough to make doctors feel safe to speak up. They must be confident they will be heard, supported and treated fairly when they raise concerns. “This survey should be a wake-up call. For one
of the NHS’s fastest growing and most crucial workforce groups, more must be done to build inclusive, supportive workplaces where they, and everyone, can thrive.” The GMC’s report – Supporting careers,
recognising contribution: locally employed (LE) and specialty, associate specialist and specialist (SAS) doctors survey 2026 – is available at: https://www.
gmc-uk.org/education/how-we-quality-assure- education-and-training/evidence-data-and- intelligence/SAS-and-LE-survey-results
Pregnant women urged to join vaccine trial to prevent GBS
Pregnant women are urged to join a world-first clinical trial testing a new vaccine which could prevent infant deaths and stillbirths from a life- threatening bacterial infection. The BEATRIX study is supported by the NIHR and sponsored by Pfizer. It is the first large-scale phase 3 vaccine trial in the world for group B streptococcus (GBS). It is being developed by researchers from the NHS and from UK universities, alongside international partners, to prevent avoidable infant deaths and stillbirths. GBS is the most common cause of life-
threatening infection in newborn babies. It causes sepsis, pneumonia and meningitis. It can kill a newborn baby within hours if untreated. Around 1
in every 1,000 babies in the UK and Ireland develops GBS infection in their first 3 months of life. Each year, GBS kills 50 babies - around 1 a week. A further 70 babies survive with long-term disabilities, such as: l hearing loss l vision problems l cerebral palsy l developmental difficulties
Professor Paul Heath, Chief Investigator of the BEATRIX study and Chair of the NIHR Vaccine Research in Pregnancy Working Group, said: “GBS can cause serious illness in newborn babies, yet there is currently no licensed vaccine available to
help prevent these infections. The BEATRIX study is evaluating an investigational maternal vaccine and aims to expand our understanding of maternal immunisation against GBS. Research such as this is important in helping build the evidence needed to address a significant unmet public health need.” Group B Strep Support, CEO Jane Plumb MBE,
said: “Antibiotics in labour save babies’ lives, but they can’t prevent late-onset GBS infections. A vaccine could change that. It could protect babies beyond birth, when today we simply don’t have a way to stop these infections happening…That’s why this trial matters so much.” To take part in the trial, women can visit: https://
tinyurl.com/5n8t2wua
November 2026 I
www.clinicalservicesjournal.com 9
News
Coetzee/
peopleimages.com -
stock.adobe.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71